Botanix Pharmaceuticals Limited
BXPHF
$0.099
-$0.001-1.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -510.81% | -416.66% | -290.08% | -176.78% | -47.71% |
| Total Depreciation and Amortization | 2,971.91% | 1,833.33% | 1,035.32% | 485.89% | -36.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 351.77% | 144.78% | -57.09% | 4.00% | 179.02% |
| Change in Net Operating Assets | -1,619.41% | -436.01% | 127.33% | 127.33% | 127.33% |
| Cash from Operations | -849.89% | -510.50% | -242.14% | -93.71% | 34.43% |
| Capital Expenditure | -148.51% | -194.57% | -333.86% | -508.55% | -1,350.98% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 95.69% | 86.37% | 76.45% | 8.76% | -147.06% |
| Cash from Investing | 94.15% | 85.14% | 75.50% | 7.76% | -148.36% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -684.57% | -90.12% | 96.93% | -- |
| Issuance of Common Stock | -59.88% | -18.57% | 89.73% | 180.13% | 327.53% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 42.53% | 5.82% | -90.54% | -173.60% | -300.21% |
| Cash from Financing | -33.66% | 0.09% | 89.45% | 179.06% | 321.40% |
| Foreign Exchange rate Adjustments | -163.83% | 23.35% | 106.12% | 83.57% | 30.68% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -121.84% | -81.11% | 213.31% | 682.15% | 2,175.12% |